|
Parameters
|
Regurgitation
|
RSI
|
GERD-HRQL
|
DMS
|
% total time
|
RE
|
|---|
|
Regurgitation
|
1.00
| | | | | |
|
RSI
|
0.70 (<0.001)
|
1.00
| | | | |
|
GERD-HRQL
|
0.59 (0.005)
|
0.71 (<0.001)
|
1.00
| | | |
|
DMS
|
−0.20 (0.399)
|
0.05 (0.838)
|
0.38 (0.107)
|
1.00
| | |
|
% total time
|
−0.12 (0.619)
|
0.12 (0.598)
|
0.41 (0.063)
|
0.94 (<0.001)
|
1.00
| |
|
RE
|
0.10 (0.667)
|
0.31 (0.167)
|
0.46 (0.035)
|
0.77 (<0.001)
|
0.84 (<0.001)
|
1.00
|
|
Crossover patients off PPIs (6 months following transoral fundoplication)
|
|
Parameters
|
Regurgitation
|
RSI
|
GERD-HRQL
|
DMS
|
% total time
|
RE
|
|
Regurgitation
|
1.00
| | | | | |
|
RSI
|
0.71 (<0.001)
|
1.00
| | | | |
|
GERD-HRQL
|
0.81 (<0.001)
|
0.62 (0.003)
|
1.00
| | | |
|
DMS
|
0.18 (0.428)
|
0.14 (0.556)
|
0.04 (0.866)
|
1.00
| | |
|
% total time
|
0.11 (0.637)
|
0.09 (0.705)
|
0.08 (0.746)
|
0.89 (<0.001)
|
1.00
| |
|
RE
|
0.17 (0.461)
|
0.14 (0.546)
|
0.14 (0.543)
|
0.65 (0.001)
|
0.80 (<0.001)
|
1.00
|
|
TF group off PPIs (12 months following transoral fundoplication)
|
|
Parameters
|
Regurgitation
|
RSI
|
GERD-HRQL
|
DMS
|
% total time
|
RE
|
|
Regurgitation
|
1.00
| | | | | |
|
RSI
|
0.66 (<0.001)
|
1.00
| | | | |
|
GERD-HRQL
|
0.42 (0.010)
|
0.73 (<0.001)
|
1.00
| | | |
|
DMS
|
0.02 (0.885)
|
0.10 (0.550)
|
0.35 (0.036)
|
1.00
| | |
|
% total time
|
0.06 (0.724)
|
0.10 (0.552)
|
0.39 (0.018)
|
0.98 (<0.001)
|
1.00
| |
|
RE
|
0.21 (0.216)
|
0.13 (0.424)
|
0.41 (0.013)
|
0.83 (<0.001)
|
0.84 (<0.001)
|
1.00
|
- Values are Spearman’s Rho (p values).
- DMS, DeMeester score; GERD-HRQL, gastroesophageal reflux disease health-related quality of life; PPI, proton pump inhibitor; RE, reflux episodes; RSI, Reflux Symptom Index.
- Regurgitation was assessed with Reflux Disease questionnaire. RSI was used to assess atypical symptoms. GERD-HRQL was used to assess typical symptoms.
